The first of its kind, Juvéderm® VOLUMA®, is a hyaluronic acid filler specifically made to restore age-related volume-loss to the mid-face (cheeks, cheekbones and around the chin).
New York, New York (PRWEB) October 18, 2013
A little volume goes a long way when it comes to an aging face. Volumizing injectables have become so popular for their ability to re-contour without permanently reconstructing the face. Plumping up the volume and lifting sagging skin is about to get even easier with the first facial filler designed for the cheek and chin area called VOLUMA®, which is expected to soon receive its FDA clearance. The first of its kind, Juvéderm® VOLUMA® is a hyaluronic acid filler specifically made to restore age-related volume-loss to the mid-face (cheeks, cheekbones and around the chin). An industry first, Voluma has been proven to last up to 18 months and provides a more smooth, natural look.
Mid-face is one of the first areas to show signs of aging – as we lose facial volume due to age and weight-loss cheeks deflate and descend while the face loses definition, balance and changes shape. VOLUMA uses hyaluronic acid, a sugar that occurs naturally in your skin, to instantly restore lost facial volume. It also combines collagen and elastin to improve skin structure and elasticity. Unlike wrinkle fillers, Voluma is suited for larger scale facial volumizing.
“Proven to provide greater volume that lasts longer than other injectables on the market, VOLUMA acts as an imaginary ‘tent pole’ under the skin – pushing up the skin and holding this effect in-place,” describes Dr. Bruce Katz, Director of The JUVA Skin & Laser Center, New York’s premier destination for the most advanced skin and laser treatments. “Because VOLUMA was developed to be smoother than other hyaluronic acid facial volumizers, it is easier to inject during treatment which results in a smooth, natural look and feel.”
In a clinical study conducted by Allergan, 102 patients with facial volume loss each received one treatment of VOLUMA dermal filler. 6 to 18 months after the treatment, an assessment found almost 65% of patients’ facial volume was rated as being ‘very much improved’. And, more than 7 out of 10 patients described their facial volume as being ‘very good’ during 6 to 18 months following the treatment. In addition, VOLUMA is associated with having lower incidences of adverse events and allergic reactions than other facial volumizers.
For more information about Juvéderm® VOLUMA®, Dr. Bruce Katz or to learn more about the JUVA Skin & Laser, please contact Alexis Tedesco of Lexamedia at alexis(at)lexamediapr(dot)com / 347.830.4004.